FEI CHEN^1,*, CHUN LUAN¹, ZICHUN WEI¹, DECHEN CAI¹, ZHIWEN CUI¹, YUYANG LI¹, HAO WU², XIAOXIA ZHANG¹, XIAOLI WU²

BIOCELL, Vol.46, No.6, pp. 1425-1433, 2022, DOI:10.32604/biocell.2022.019868

Abstract The coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed a potential threat to infant health. The World Health Organization recommended that the benefits of breastfeeding far outweigh the potential risk of transmission, but there is no denying that the current evidence is insufficient. Moreover, although the COVID-19 mRNA vaccine has played an effective role in protection against infection, individuals have increasing concerns about the safety of breastfeeding after vaccination, and which have caused some breastfeeding women to postpone vaccination or stop breastfeeding early. Thus, in this review, we provide an in-depth… More >

Delphine Déniel^1,2,*, Fabienne Le Goc-Le Sager¹, Paul Touchard³, Véronique Marty⁴, Laurence Hasle⁵, Véronique Jestin Le Tallec⁶, Monique Jegaden⁷, Annaïk Pestel⁸, Virginie Jannou⁵, Sophie Pentecôte⁹, Laurence Guen^1,2, Christophe Perrin^1,10, Sandrine Estivin^1,3

Oncologie, Vol.23, No.4, pp. 453-461, 2021, DOI:10.32604/oncologie.2021.019964

Abstract Context: Since January 2021, vaccination for COVID-19 has been made possible in France for people aged 75 and over. Patients suffering from a cancer disease are part of a group at risk to develop severe complications to COVID-19. Method: The « Unité de coordination en Onco-Gériatrie région Bretagne » (the Brittany This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Coordinating Unit in Onco-Geriatrics) has wished to set up an inquest about the acceptability and the tolerance to COVID-19 vaccination… More >

R. Sujatha¹, B. Venkata Siva Krishna¹, Jyotir Moy Chatterjee², P. Rahul Naidu¹, NZ Jhanjhi^3,*, Challa Charita¹, Eza Nerin Mariya¹, Mohammed Baz⁴

Intelligent Automation & Soft Computing, Vol.32, No.1, pp. 525-541, 2022, DOI:10.32604/iasc.2022.021216

Abstract In the current times, COVID-19 has taken a handful of people’s lives. So, vaccination is crucial for everyone to avoid the spread of the disease. However, not every vaccine will be perfect or will get success for everyone. In the present work, we have analyzed the data from the Vaccine Adverse Event Reporting System and understood that the vaccines given to the people might or might not work considering certain demographic factors like age, gender, and multiple other variables like the state of living, etc. This variable is considered because it explains the unmentioned variables like their food habits and… More >

Fareeha Sameen¹, Abdul Momin Kazi², Majida Kazmi^1,*, Munir A Abbasi³, Saad Ahmed Qazi^1,4, Lampros K Stergioulas^3,5

CMC-Computers, Materials & Continua, Vol.70, No.1, pp. 375-395, 2022, DOI:10.32604/cmc.2022.019167

Abstract Routine immunization (RI) of children is the most effective and timely public health intervention for decreasing child mortality rates around the globe. Pakistan being a low-and-middle-income-country (LMIC) has one of the highest child mortality rates in the world occurring mainly due to vaccine-preventable diseases (VPDs). For improving RI coverage, a critical need is to establish potential RI defaulters at an early stage, so that appropriate interventions can be targeted towards such population who are identified to be at risk of missing on their scheduled vaccine uptakes. In this paper, a machine learning (ML) based predictive model has been proposed to… More >

Nikita Jain¹, Vedika Gupta^1,*, Chinmay Chakraborty², Agam Madan¹, Deepali Virmani³, Lorenzo Salas-Morera⁴, Laura Garcia-Hernandez⁴

CMC-Computers, Materials & Continua, Vol.70, No.1, pp. 213-231, 2022, DOI:10.32604/cmc.2022.016424

Abstract COVID-19 has become one of the critical health issues globally, which surfaced first in latter part of the year 2019. It is the topmost concern for many nations’ governments as the contagious virus started mushrooming over adjacent regions of infected areas. In 1980, a vaccine called Bacillus Calmette-Guérin (BCG) was introduced for preventing tuberculosis and lung cancer. Countries that have made the BCG vaccine mandatory have witnessed a lesser COVID-19 fatality rate than the countries that have not made it compulsory. This paper’s initial research shows that the countries with a long-term compulsory BCG vaccination system are less affected by… More >

Gabriele Egidy Assenza¹, Biagio Castaldi^2,*, Serena Flocco³, Giovanni Battista Luciani⁴, Giovanni Meliota⁵, Gabriele Rinelli⁶, Ugo Vairo⁵, Silvia Favilli⁷, Board of the Italian Society of Pediatric Cardiology

Congenital Heart Disease, Vol.16, No.5, pp. 427-431, 2021, DOI:10.32604/CHD.2021.016713

Abstract COVID-19 pandemic continues to strike across the world with increasing number of infected patients, severe morbidity and mortality, social life and economy disruption. Universal access to vaccine prophylaxis will be pivotal in controlling this infection and providing individual level protection. However, mismatch between vaccine request and vaccine availability, as well as constraints in logistics of vaccine campaign is creating a transition phase of progressive but still incomplete inclusion of group of individuals in the vaccination process. Selected patients living with chronic and multisystemic disease may present increased propensity of adverse outcome, should Sars-Cov-2 infection develop. In these patients, expedite access… More >

WENJUAN LI^*, GE SONG

BIOCELL, Vol.44, No.2, pp. 127-135, 2020, DOI:10.32604/biocell.2020.010018

Abstract From late December 2019 a new human-adapted coronavirus, SARS-CoV-2, was observed and isolated in clustered patients in Wuhan, China. It has been proved to be able to transmit human-to-human and cause pneumonia, leading to about 2% fatality. Its genome characteristics, immune responses and related potential treatments, such as chemical drugs, serum transfusion and vaccines including DNA vaccines, are discussed in this review for a brief summary. More >